Continuum Clinical Can Provide Rescue Support for a Patient Recruitment Campaign Within Four Weeks
Not connecting with a targeted audience, failing to retain patients throughout the enrollment process, and not having relationships with study coordinators at the site level are just a few reasons why a clinical trial may not meet its initial enrollment goals and would need to quickly turn things around. When a Sponsor runs into any […]
How Study Sites Can Overcome the Great Resignation to Achieve Minimal Disruption to Drug Development
The COVID-19 pandemic and the Great Resignation have affected pharmaceutical companies and study sites. As more companies offer the option to work from home, study coordinators are leaving their profession for jobs that offer a better work-life balance. What was once a routine process of funneling patients to a study site, participating in a clinical […]
Supporting Site Enrollment During COVID-19: Part Two
The impact COVID-19 has had on clinical trial operations – and especially sites’ ability to enroll patients – continues to be enormous. There are no easy answers; avoiding significant pandemic-related disruptions to trial timelines requires both an agile approach to patient engagement and a close eye on critical data. In this two-part series, we will […]
Supporting Site Enrollment During COVID-19: A Two Part Series
The impact COVID-19 has had on clinical trial operations – and especially sites’ ability to enroll patients – continues to be enormous. There are no easy answers; avoiding significant pandemic-related disruptions to trial timelines requires both an agile approach to patient engagement and a close eye on critical data. In this two-part series [click to […]
Need to recruit patients even as COVID cases spike? A Physician Referral Network may be your most reliable option.
As sponsors work to keep clinical trials on track amidst pandemic-related restrictions, patient recruitment has become an increasing concern. One tactic that is yielding excellent results is a Physician Referral Network—a service from Continuum Clinical that engages and educates physicians about a clinical trial with the purpose of having the treating physicians identify and refer […]
COVID-19 Live Updates
Updated 21-JULY-2020 In partnership with ZS Associates, we connected with 1,250 patients globally to understand the impact of COVID-19 on clinical trials. See the infographic below for a quick summary of our findings, or download the report for a deeper dive. Updated 10-JUN-2020 Number of Clinical Research Sites Fearing Total Closure Drops by 71% in […]
For Autoimmune Patients, Flattening the Curve May Not Be Enough
Social distancing. Fear of infection. Major life disruptions. For most, these concerns are new, and related directly to COVID-19. But for people living with autoimmune diseases like lupus, RA, Crohn’s and colitis, these concerns are present every day. Even so, autoimmune patients have historically been willing to participate in clinical research despite the risks. But […]
Enrollment Pause or Delay? A Catalyst Campaign Will Keep You on Track to Meet Milestones
The coronavirus (COVID-19) pandemic is causing major disruptions to clinical trials, with one third of study sites anticipating closure and nearly 80% reporting at least one ongoing trial has been put on hold, according to a US site survey conducted by Continuum and the ACRP. Since sites are largely unable to screen new patients, many […]
NASH Conversations in Idle: 2020 Social Listening and Study Site Survey
In 2018 Continuum Clinical conducted a social intelligence report—an analysis of online conversations centered around NASH. The report identified four key conversation themes: patient frustration, self-advocacy & community engagement, disruption, and lifestyle impact. The themes provided us with valuable insight into the NASH patient population and an understanding of overall NASH awareness. This year, in […]
How to Unlock ROI in Under-Performing Study Sites
Long before your study’s first randomization, before the first screening visit is scheduled, even before the very first patient is referred, sponsors have already invested upwards of $2 million just in selecting and training qualified study sites. The magnitude of this investment shouldn’t come as a surprise: proper site selection dramatically and directly impacts the […]